4.7 Review

Time-Restricted Eating and Metabolic Syndrome: Current Status and Future Perspectives

期刊

NUTRIENTS
卷 13, 期 1, 页码 -

出版社

MDPI
DOI: 10.3390/nu13010221

关键词

time-restricted eating; metabolic syndrome; abdominal obesity; hyperglycemia; dyslipidemia; inflammation; oxidative stress; cardiometabolic risk; circadian rhythm; eating pattern

向作者/读者索取更多资源

Metabolic syndrome affects about 30% of adults, posing increased risks of cardiovascular diseases and diabetes. Irregular eating patterns in MetS patients can disrupt circadian rhythms, leading to adverse metabolic health. Implementing time-restricted eating (TRE) shows promising outcomes in improving cardiometabolic health in MetS individuals.
Metabolic syndrome (MetS) occurs in similar to 30% of adults and is associated with increased risk of cardiovascular disease and diabetes mellitus. MetS reflects the clustering of individual cardiometabolic risk factors including central obesity, elevated fasting plasma glucose, dyslipidemia, and elevated blood pressure. Erratic eating patterns such as eating over a prolonged period per day and irregular meal timing are common in patients with MetS. Misalignment between daily rhythms of food intake and circadian timing system can contribute to circadian rhythm disruption which results in abnormal metabolic regulation and adversely impacts cardiometabolic health. Novel approaches which aim at restoring robust circadian rhythms through modification of timing and duration of daily eating represent a promising strategy for patients with MetS. Restricting eating period during a day (time-restricted eating, TRE) can aid in mitigating circadian disruption and improving cardiometabolic outcomes. Previous pilot TRE study of patients with MetS showed the feasibility of TRE and improvements in body weight and fat, abdominal obesity, atherogenic lipids, and blood pressure, which were observed despite no overt attempt to change diet quantity and quality or physical activity. The present article aims at giving an overview of TRE human studies of individuals with MetS or its components, summarizing current clinical evidence for improving cardiometabolic health through TRE intervention in these populations, and presenting future perspectives for an implementation of TRE to treat and prevent MetS. Previous TRE trials laid the groundwork and indicate a need for further clinical research including large-scale controlled trials to determine TRE efficacy for reducing long-term cardiometabolic risk, providing tools for sustained lifestyle changes and, ultimately, improving overall health in individuals with MetS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据